Support PBS listing for pembrolizumab
23 August 2018
Pembrolizumab is being considered by the Pharmaceutical Benefits Advisory Committee (PBAC) at a meeting in November 2018 for reimbursement on the PBS for the adjuvant treatment of patients with resected Stage III melanoma.
As part of the PBAC process, clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing.
Interested parties will be able to make a submission to the PBAC from now until Wednesday 3 October 2018.
Submissions can be made as follows:
1. Email your input directly to the PBAC at CommentsPBAC@health.gov.au
2. Mail your submission to the PBAC Secretariat: MDP 952, Department of Health and Ageing, GPO Box 9848, Canberra ACT 2601
3. There is also an online portal for submission here
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.